Exane Derivatives’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-930
Closed -$110K 921
2022
Q1
$110K Buy
+930
New +$118K 0.03% 461
2021
Q4
Sell
-3,153
Closed -$344K 971
2021
Q3
$344K Hold
3,153
0.08% 255
2021
Q2
$400K Sell
3,153
-997
-24% -$128K 0.09% 234
2021
Q1
$505K Buy
4,150
+984
+31% +$124K 0.14% 145
2020
Q4
$380K Buy
+3,166
New +$323K 0.11% 216
2019
Q2
Sell
-914
Closed -$36.4K 716
2019
Q1
$36.4K Buy
+914
New +$34.2K 0.01% 353

Other funds holding TER

Exane Derivatives's TER Position: Q2 2022 in Review

Exane Derivatives sold out of Teradyne (TER) in Q2 2022, closing a stake of 930 shares — an estimated $110K sold.

Exane Derivatives first reported a position in TER in Q1 2019 and held it in 6 quarters. The position peaked at $505K in Q1 2021. 654 funds tracked by Wall St. Rank hold TER as of Q2 2022.

  • Exane Derivatives reported no remaining Teradyne position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 930 Teradyne shares in Q2 2022, an estimated $110K.
  • Exane Derivatives first reported a position in Teradyne in Q1 2019 and held it in 6 quarters.
  • Exane Derivatives's Teradyne position peaked at $505K in Q1 2021.
  • 654 funds tracked by Wall St. Rank held Teradyne as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.